Wayne Forrest[email protected]Nuclear MedicineReport: U.S. therapeutic radiopharma market set for growthFueled by new radiopharmaceuticals to treat various forms of cancer, U.S. sales of therapeutic radiopharmaceuticals over the next several years could reach $5.8 billion by 2020, according to a new market research report from Bio-Tech Systems.December 19, 2012Nuclear MedicineCMS proposal could ease payment path for oncology PET tracersThe U.S. Centers for Medicare and Medicaid Services (CMS) this week proposed a new policy that could make it easier for new oncology PET tracers to win reimbursement. PET advocates are disappointed, however, that the change won't apply to tracers used for neurology and cardiology applications.December 13, 2012Nuclear MedicineAdding MRI and PET to biomarkers helps predict Alzheimer'sThe combination of 1.5-tesla MRI, FDG-PET, and cerebrospinal fluid data when added to routine clinical tests significantly increases the ability to predict whether people with mild cognitive impairment will progress to Alzheimer's disease, according to a study published online December 11 in Radiology.December 10, 2012Nuclear MedicineFDA gives PET drugmakers until 2015 to comply with new rulesThe U.S. Food and Drug Administration this week set a December 12, 2015, deadline for PET drug manufacturers to operate under an approved new drug application (NDA), abbreviated new drug application (ANDA), or investigational new drug (IND) submission to continue to make their products.December 5, 2012Nuclear MedicineC-11 methionine PET aids diagnosis of adenomas, multiple myelomaThe radiotracer carbon-11 (C-11) methionine (MET) with PET/CT can help clarify negative or inconclusive FDG-PET findings in multiple myeloma patients, as well as differentiate between atypical and typical pituitary adenomas, according to two Japanese studies presented at last week's RSNA 2012 conference.December 2, 2012BreastLow-dose mammo, wireless US probe, 3T MRI pace Siemens at RSNACHICAGO - A new digital mammography system with lower radiation dose, a wireless ultrasound probe, a 3-tesla MRI scanner designed for high-performance clinical and research work, and a new line of angiography systems are among the highlights in the RSNA 2012 booth of Siemens Healthcare.November 27, 2012Nuclear MedicineLow-dose MBI as effective as mammo in screening dense breastsCHICAGO - Low-dose molecular breast imaging (MBI) can outperform screening mammography to detect cancer in women with dense breasts, according to a study presented on Tuesday at the annual RSNA meeting.November 27, 2012Nuclear MedicinePET/MRI matches PET/CT for gynecological malignanciesCHICAGO - PET/MRI can be comparable to PET/CT and holds "great promise" for patients with gynecological malignancies, potentially reducing scan time and radiation exposure, according to a study presented on Monday at the RSNA annual meeting.November 26, 2012MRIMRI shows physical activity can slow dementia, Alzheimer'sCHICAGO - By using voxel-based morphometry of high-resolution MR images, researchers have discovered that physically active adults have a greater preservation of brain structure and gray matter, according to a presentation at the RSNA meeting.November 25, 2012Nuclear MedicinePET/MRI tops DWI-MRI for head/neck lymph node metastasesCHICAGO - PET/MRI outperformed diffusion-weighted MRI (DWI-MRI) for detecting lymph node metastases in the staging of head and neck cancer patients, according to a study presented on Sunday at the RSNA annual meeting.November 24, 2012Previous PagePage 137 of 239Next PageTop StoriesMolecular ImagingComing soon? 'Regenerative imaging'A CRISPR/Cas9 gene imaging system advances the field of regenerative imaging for stem cell tracking in stroke.MRICombination of osmotically active agents improve drug delivery to brainCTFollow-up analysis shows ELCAP's continued efficacy for CVD predictionWomens ImagingNode-RADS evaluates breast cancers on MRI examsSponsor Content"Join Us"